Company Description: Monument Tx is a clinical stage neuroscience-specialist drug development company. Taking our cue from oncology, we aim to radically reduce drug development timeframes, and increase success rates, by applying a stratified medicine approach to neuroscience. We use proprietary digital biomarkers to detect subgroups of patients with common underlying biological abnormalities. We then treat these patients with proprietary reformulations of drugs that provide strong IP and product differentiation but an accelerated route to market.